RE:RE:RE:RE:Another look at the dataThanks S&B, I always thought that if we could see how the 12 under treated skewed the results obviously the FDA would see it and take it into consideration. It's eerie how that and the covid delays could mean that this all comes together as Roger's suspension is due to end. Maybe it is that and not some toxic work environment that some have suggested for the rotating executives, Vera aside since it seems like maybe she more of a consultant. Anyway as you say it looks good.
stocksnbonds458 wrote: Dawg, from what I understand after talking with someone close to the situation is that the FDA have had a number of conversations with TLT managent regarding BTD and the progress of their therapy. I was also told that the FDA has the discretion to "read between the lines" with regards to results, with the possibility that they could disregard much of the botched "first 12" from phase 2. I also believe this is why many of the longs have become more hopeful than ever, and also may be why we have seen such strong insider buying. Nothing is ever certain, but it sure does look good!